Birth Experience During COVID-19 Confinement
CONFINE
1 other identifier
interventional
927
1 country
1
Brief Summary
Different studies have demonstrated that the absence of companionship during labor and childbirth may be responsible for a negative birth experience, an increased risk of postnatal depression and/or post traumatic stress disorders. These situation may also have a negative impact on mother-child interaction, on marital and family relationship and on the rate of maternal suicide in postpartum. However, these previous results cannot be extrapolated in the current context where the absence of the companionship is imposed by the confinement framework. The objective of the CONFINE study is to assess, for the first time, the birth experience of women in the context of limited social support in the immediate post-partum period due to confinement, as well as the associated over-risk of mental disorders, compared to a post-partum without social restriction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2020
CompletedFirst Posted
Study publicly available on registry
April 16, 2020
CompletedStudy Start
First participant enrolled
April 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2023
CompletedFebruary 8, 2024
February 1, 2024
3.3 years
April 10, 2020
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
"Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay)
through study completion, an average of 16 months
Secondary Outcomes (7)
"Labor Agentry Scale questionnaire" score at two months after birth
through study completion, an average of 16 months
Edinburg Postnatale Depression Scale questionnaire" score at two months after birth
through study completion, an average of 16 months
"Impact of Event Scale - Revised questionnaire" score at two months after birth
through study completion, an average of 16 months
Breastfeeding statement at two months after birth
through study completion, an average of 16 months
"SF-12 Quality of life questionnaire" score at two months after birth
through study completion, an average of 16 months
- +2 more secondary outcomes
Study Arms (3)
Confinement group
EXPERIMENTALDelivery during covid-19 confinement period
Control group
OTHERDelivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)
Epidemic group
OTHERDelivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
Interventions
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Eligibility Criteria
You may qualify if:
- Woman who is \>= 18 years old
- Woman having just given birth from 37 weeks of gestation (singleton pregnancy)
- Woman affiliated to a social security
- Woman with a level of understanding of written French sufficient to answer the questionnaires.
- Woman having received complete information on the organization of the research and having given her informed consent in written form.
- For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
- For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)
You may not qualify if:
- Major mentioned in articles L.1121-6 and L-1121-8 of Health Public Code.
- Woman with psychiatric disorders such as depressive syndrome
- Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result)
- Newborn with congenital abnormalities
- Stillbirth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Régional Universitaire de Nancy
Nancy, 54000, France
Related Publications (1)
Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.
PMID: 33303470DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Charline BERTHOLDT
Central Hospital, Nancy, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator (obstetrician-gynecologist)
Study Record Dates
First Submitted
April 10, 2020
First Posted
April 16, 2020
Study Start
April 16, 2020
Primary Completion
July 21, 2023
Study Completion
July 21, 2023
Last Updated
February 8, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
All data generated during this study will be made available via CIC-EC, CHRU Nancy, Nancy- FRANCE in accordance with protocol promotor. Data obtained from this study will be deposited at CIC-EC Nancy where they will be maintained for a minimum of 15 years.